RenaissanceRe reported strong second-quarter 2026 results, with net income available to common shareholders of $654.2 million and operating income available to common shareholders of $547.8 million. The company delivered a 72.8% combined ratio, net investment income of $432.5 million and repurchased $350.0 million of common shares in the quarter. Book value per common share increased 5.7% quarter-over-quarter to $264.77.

Financial Highlights

  • Net income available to common shareholders: $654.234 million for Q2 2026.
  • Operating income available to common shareholders: $547.761 million for Q2 2026.
  • Net income per diluted common share: $15.48; Operating income per diluted common share: $12.92.
  • Combined ratio: 72.8%; Adjusted combined ratio: 71.7%.
  • Net investment income: $432.489 million; net realized and unrealized gains on investments: $121.628 million.

Business Highlights

  • Underwriting performance balanced across three drivers of profit — Underwriting, Fee and Net Investment Income — with underwriting income of $599.1 million for the quarter.
  • Property segment produced a strong combined ratio of 27.1%, driven by low current-year catastrophe losses and $257.5 million of favorable prior-year development in Property.
  • Casualty and Specialty segment saw a combined ratio of 103.3%, with $58.0 million of adverse prior-year development (including $54.0 million reallocated from Property for the Baltimore Bridge Collapse).
  • Fee income of $83.0 million with contributions from management and performance fees; $59.4 million of fee income recorded in net income attributable to redeemable noncontrolling interests.
  • Active capital management: repurchased 1.2 million common shares for $350.0 million in Q2 2026 and repurchased an additional $82.9 million of shares through July 20, 2026.

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.